Atlas market file · Etf · United States
Defiance Daily Target 2X Long AVGO ETFAVGX
- Last close
- 56.02
- Change
- +1.08%
- 96-bar range
- 30.84 – 84.8
- As of
- 6 Aug 2026
Defiance Daily Target 2X Long AVGO ETF is an exchange-traded fund listed as AVGX on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+179.55% over the window).
Source rail: Yahoo Finance chart API (AVGX). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for AVGX. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
AVGX public profile
Exchange-traded fund. Defiance Daily Target 2X Long AVGO ETF is connected to current market context, cited company sources and its retained research file.
Defiance Daily Target 2X Long AVGO ETF trades as AVGX on NASDAQ. Defiance Daily Target 2X Long AVGO ETF (AVGX) has a latest verified close of 56.02, up 1.08%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. AVGX stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for Defiance Daily Target 2X Long AVGO ETF today
The Defiance Daily Target 2X Long AVGO ETF (AVGX) is marketed as the first ETF targeting Nasdaq-100 Ex-Software Companies, a niche that sounds sophisticated until you notice the 0.95% annual fee tagging along like an uninvited plus-one. The fund’s own FAQ page cheerfully explains that if the underlying basket rises 1%, the concentrated share can rise 2%-before fees and expenses, of course. The fine print also reminds investors that leverage works in both directions, which is the ETF equivalent of handing someone a flamethrower while saying “try not to burn the house down.” The issuer’s home page features a slide deck with two hands high-fiving over a Nasdaq screen, a visual metaphor for the distance between polished marketing and the mechanical grind of compound decay. (source: Defiance ETFs FAQ Document, https://www.defianceetfs.com/faqs/)
AVGX is not an index fund; it is a daily 2x concentrated bet on a subset of the Nasdaq-100 that excludes software, a lineup that is neither fish nor fowl in a tech index. The fund’s prospectus repeats three marketing lines like a broken record-“ETFs built for the next generation,” “the first ETF targeting Nasdaq-100 Ex-Software Companies,” and “leading the wave in ETF innovation”-while the SEC filing treats the product as a standard ETF, meaning the novelty is the wrapper, not the underlying logic. The fund’s expense ratio is 0.95%, which is high enough to fund a small team of marketers and a few more executives who can explain why the fee is “competitive” in a crowded concentrated-ETF aisle. (source: SEC EDGAR fund search for AVGX, https://www.sec.gov/edgar/search/#/q=AVGX)
The fund’s operating mandate is a daily reset of 2x exposure to the Nasdaq-100 ex-software index, a mechanism that compounds decay faster than a concentrated ETF on a meme-stock Friday afternoon. The issuer’s own slides trumpet “innovation,” yet the operating reality is a fee that silently compounds on the way to mediocre performance in anything but the calmest markets. Defiance ETFs acts as the investment adviser, which means it provides investment management services-i.e., charges a fee-while the fund’s Nasdaq listing page shows the usual ETF plumbing: creation units, redemptions, and a market price that will wander between fair value and whatever the market can bear. The leverage is the story; the fee is the storyteller. (source: Defiance ETFs Home, https://www.defianceetfs.com)
If you want to see where AVGX trades, the Nasdaq listing page is the cleanest source, though it will not tell you whether the fund is delivering 2x the index ex-software after fees. The fund’s expense ratio of 0.95% is baked in every day, and the daily reset means compounding works against you when volatility inevitably arrives. The fund’s marketing materials are polished, but the mechanical reality is a concentrated nail-biter with a built-in management toll. For a sense of the fund’s structure and fees, the FINRA Fund Analyzer provides a side-by-side comparison with other concentrated ETFs, though it will not change the arithmetic of decay. (source: Nasdaq AVGX market activity, https://www.nasdaq.com/market-activity/etf/avgx; FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)
The fund’s prospectus does not contain a crystal ball, and neither does the index methodology. The Nasdaq-100 ex-software exclusion is a defined mechanical screen, not an investment thesis, so the fund’s returns will track the daily beta of a narrow basket minus fees and compound decay. The issuer’s news rail repeats the same three marketing lines across its site, which suggests the real innovation is the consistency of the messaging rather than the investment outcome. The fund’s operating mechanics are public; the marketing promise is louder. (source: Defiance ETFs Prospectuses, https://www.defianceetfs.com/prospectuses/)
There is no earnings release to parse, no revenue to tally, and no dividend to bank. AVGX is a rules-based concentrated product, not a company, so the only numbers that matter are the expense ratio (0.95%), the leverage (2x daily), and the index exclusion (software). The fund’s marketing materials are vivid, but the operating reality is a spreadsheet with a fee. The Nasdaq listing page shows the market price; the rest is marketing theatre. (source: Defiance ETFs News & Insights, https://www.defianceetfs.com/in-the-news/)
Sources & evidence · 8 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
AVGX technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on AVGX
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep AVGX research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
AVGX FAQ
What is Defiance Daily Target 2X Long AVGO ETF (AVGX)?Defiance Daily Target 2X Long AVGO ETF (AVGX) has a latest verified close of 56.02, up 1.08%, dated 6 Aug 2026. Use this page to check the price chart, company context,...
Defiance Daily Target 2X Long AVGO ETF (AVGX) has a latest verified close of 56.02, up 1.08%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for AVGX?Defiance Daily Target 2X Long AVGO ETF (AVGX) has a latest verified close of 56.02, up 1.08%, dated 6 Aug 2026. It brings the latest available chart, company context,...
Defiance Daily Target 2X Long AVGO ETF (AVGX) has a latest verified close of 56.02, up 1.08%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. AVGX stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the AVGX page updated?The AVGX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The AVGX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for AVGX?The AVGX file starts with Nasdaq Trader and TradingView NASDAQ:AVGX. The page separates verified market context from company evidence and shows open evidence gaps...
The AVGX file starts with Nasdaq Trader and TradingView NASDAQ:AVGX. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on AVGX?Yes. The workstation can open AVGX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open AVGX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this AVGX page investment advice?No. The AVGX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The AVGX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
AVGX
Etf · evidence first